awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33633424-A2AAF7D3-FC77-4B98-95E2-9A5C8F98D448
Q33633424-A2AAF7D3-FC77-4B98-95E2-9A5C8F98D448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-A2AAF7D3-FC77-4B98-95E2-9A5C8F98D448
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.
P2860
Q33633424-A2AAF7D3-FC77-4B98-95E2-9A5C8F98D448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-A2AAF7D3-FC77-4B98-95E2-9A5C8F98D448
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4348b9bfecc1351499192d9273e048bd3f660e13
P2860
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.